These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2261824)

  • 21. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycaemic control and its determinants in diabetic patients in Ethiopia.
    Gebre-Yohannes A; Rahlenbeck SI
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):129-34. PubMed ID: 9179468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors related to glycemic control in IDDM and insulin-treated NIDDM patients in current practice. A comparison of care policies. SIEMTIC Group. Studio Italiano Epidemiologico Multicentrico su Terapia Insulin e Controllo Metabolico.
    Garancini MP; Gallus G; Cucinotta D; Rossi A; Riccardi G
    Diabetes Care; 1997 Nov; 20(11):1659-63. PubMed ID: 9353604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
    Vaag A; Alford F; Beck-Nielsen H
    Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term and long-term memory in elderly patients with NIDDM.
    Helkala EL; Niskanen L; Viinamaki H; Partanen J; Uusitupa M
    Diabetes Care; 1995 May; 18(5):681-5. PubMed ID: 8586007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
    Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using the Common Sense Model of Self-regulation to review the effects of self-monitoring of blood glucose on glycemic control for non-insulin-treated adults with type 2 diabetes.
    Breland JY; McAndrew LM; Burns E; Leventhal EA; Leventhal H
    Diabetes Educ; 2013; 39(4):541-59. PubMed ID: 23749773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An assessment of attitudes, behaviors, and outcomes of patients with type 2 diabetes.
    Daly JM; Hartz AJ; Xu Y; Levy BT; James PA; Merchant ML; Garrett RE
    J Am Board Fam Med; 2009; 22(3):280-90. PubMed ID: 19429734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus.
    Al-Khawaldeh OA; Al-Hassan MA; Froelicher ES
    J Diabetes Complications; 2012; 26(1):10-6. PubMed ID: 22226484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An ecological perspective on diabetes self-care support, self-management behaviors, and hemoglobin A1C among Latinos.
    Soto SC; Louie SY; Cherrington AL; Parada H; Horton LA; Ayala GX
    Diabetes Educ; 2015 Apr; 41(2):214-23. PubMed ID: 25656696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus.
    Pecoraro RE; Koepsell TD; Chen MS; Lipsky BA; Belcher DW; Inui TS
    Diabetes Care; 1986; 9(4):370-5. PubMed ID: 3743312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
    Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
    Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling the effect of diabetes education on glycemic control.
    Peyrot M; Rubin RR
    Diabetes Educ; 1994; 20(2):143-8. PubMed ID: 7851228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Benefits of blood glucose self-monitoring in the management of insulin-dependent (IDDM) and non-insulin-dependent diabetes (NIDDM). Analysis of the literature: mixed results].
    Halimi S
    Diabetes Metab; 1998 Nov; 24 Suppl 3():35-41. PubMed ID: 9881230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biobehavioral determinants of glycemic control in type 2 diabetes: A systematic review and meta-analysis.
    Brown SA; García AA; Brown A; Becker BJ; Conn VS; Ramírez G; Winter MA; Sumlin LL; Garcia TJ; Cuevas HE
    Patient Educ Couns; 2016 Oct; 99(10):1558-67. PubMed ID: 27036083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of metabolic control and body weight to hypercholesterolemia in NIDDM patients with apolipoprotein E4.
    Eto M; Watanabe K; Makino I
    Diabetes Care; 1991 Feb; 14(2):127-9. PubMed ID: 2060414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
    Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
    Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical usefulness of glucated haemoglobin in diabetes care evaluated by use of a medical technology assessment strategy.
    Larsen ML
    Dan Med Bull; 1997 Jun; 44(3):303-15. PubMed ID: 9233549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of barriers and self-efficacy on self-care behaviors in type 2 diabetes.
    Aljasem LI; Peyrot M; Wissow L; Rubin RR
    Diabetes Educ; 2001; 27(3):393-404. PubMed ID: 11912800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.